Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.60
Bid: 42.48
Ask: 42.56
Change: -0.08 (-0.19%)
Spread: 0.08 (0.188%)
Open: 42.86
High: 42.86
Low: 42.10
Prev. Close: 42.68
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Markets Event

8 Feb 2024 14:00

RNS Number : 4858C
Assura PLC
08 February 2024

8 February 2024

Assura plc

Capital markets event

Assura plc ("Assura"), the leading primary care property investor and developer, is today hosting a capital markets presentation and site tour for analysts and institutional investors.

Assura has identified several areas of emerging opportunities (NHS Trusts, private providers, mental health and Ireland) that are now becoming meaningful contributors to our portfolio, rental income and cash flow.

Members of the senior management team will present an update on our strategic approach to these emerging opportunities, outlining why we are targeting these areas alongside our existing GP medical centres and how our skills and capabilities mean we are well placed to become a market leader.

Specifically focused on the private market, the presentation will detail:

· The state of the UK healthcare market and resultant increasing demand for high-quality, sustainable healthcare buildings in a community setting

· Overview of trends and market opportunity in the private market segment

· Assura's capabilities in capturing this opportunity; to complement its existing GP centre portfolio

· An overview of recent private market development completions

· Recent investments and asset enhancements within the mental health segment will also be highlighted

There will be a subsequent site tour to showcase Assura's recently completed, state-of-the-art cancer care facility in Guildford.

Jonathan Murphy, CEO of Assura, said: "There is significant demand for high-quality, sustainable healthcare buildings in a community setting to alleviate the considerable and growing pressures facing the NHS whilst improving the significantly underinvested existing estate. Each of these emerging areas is closely aligned with Assura's existing portfolio to relieve pressure on the health system; has attractive investment characteristics with a strong underlying tenant covenant and offers opportunities for future growth, which Assura is well placed to capture."

No new material trading information will be disclosed. A copy of the presentation is available on the Assura plc website at: https://www.assuraplc.com/investor-relations/reports-and-presentations

- ENDS -

Assura plc David Purcell, Investor Relations Director

Tel: 0161 515 2043 Email: Investor@assura.co.uk

FGS Global

Gordon SimpsonGrace Whelan

Tel: 0207 251 3801 Email: Assura@fgsglobal.com

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026.

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
UPDUWAWRSBUURRR
Date   Source Headline
10th Nov 202011:54 amRNSDirector/PDMR Shareholding
5th Nov 20209:52 amRNSNotice of Interim Results
4th Nov 20207:00 amRNSIssue of Consideration Shares
22nd Oct 20204:48 pmRNSHolding(s) in Company
19th Oct 202012:13 pmRNSDirector/PDMR Shareholding
12th Oct 20204:54 pmRNSScrip Dividend Declaration
7th Oct 202012:11 pmRNSDirector/PDMR Shareholding
7th Oct 202012:05 pmRNSCorrection to Trading Update
7th Oct 20207:00 amRNSTrading Update
25th Sep 20201:50 pmRNSHolding(s) in Company
23rd Sep 202012:07 pmRNSDirector/PDMR Shareholding
17th Sep 202010:30 amRNSScrip Calculation Price
16th Sep 20207:00 amRNSVirtual Property Tour
8th Sep 20204:19 pmRNSPricing of £300m Social Bond
4th Sep 20202:36 pmRNSDirector/PDMR Shareholding
4th Sep 20202:34 pmRNSAdditional Listing
3rd Sep 20201:31 pmRNSNotice of Dividend
20th Aug 20203:02 pmRNSNotification of Major Interests in Shares
3rd Aug 202011:11 amRNSDirector/PDMR Shareholding
24th Jul 20203:04 pmRNSExercise of Nil Cost Options under PSP
21st Jul 20207:00 amRNSAdditional Listing
16th Jul 20207:00 amRNSDirector/PDMR Shareholding
14th Jul 202012:54 pmRNSPDMR Notification
9th Jul 20207:00 amRNSScrip Dividend Declaration
8th Jul 20201:42 pmRNSNotification of Major Interests in Shares
7th Jul 20203:12 pmRNSResult of AGM
7th Jul 20207:00 amRNSTrading update
1st Jul 20201:25 pmRNSNotification of Major Interests in Shares
24th Jun 20208:00 amRNSNotification of Major Interests in Shares
18th Jun 20202:43 pmRNSScrip Calculation Price
15th Jun 20205:15 pmRNSNotification of Major Interests in Shares
12th Jun 20203:54 pmRNSDirector/PDMR Shareholding
12th Jun 202011:47 amRNSAmended Notice of AGM
9th Jun 20202:04 pmRNSAnnual Report and Notice of AGM
4th Jun 202010:01 amRNSNotice of dividend
21st May 20207:00 amRNSAssura Full Year Results
11th May 20207:00 amRNSConfirmation of announcement date for results
16th Apr 202010:50 amRNSDirector/PDMR Shareholding
14th Apr 202012:38 pmRNSReplacement Scrip Dividend Declaration
14th Apr 20207:00 amRNSNotification of Major Interests in Shares
14th Apr 20207:00 amRNSNotification of Major Interests in Shares
9th Apr 20207:00 amRNSScrip Dividend Declaration
7th Apr 20207:00 amRNSResults of Placing
6th Apr 20204:42 pmRNSProposed equity placing of new ordinary shares
2nd Apr 20207:00 amRNSTrading update
20th Mar 20207:00 amRNSScrip Calculation Price
13th Mar 20204:46 pmRNSNotification of Major Interests in Shares
5th Mar 20207:00 amRNSNotice of Dividend
24th Feb 20203:40 pmRNSNotification of Major Interests in Shares
20th Feb 20209:13 amRNSNotification of Major Interests in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.